Page last updated: 2024-11-03

opc 12759 and Metaplasia

opc 12759 has been researched along with Metaplasia in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lee, JS1
Jeon, SW1
Lee, HS1
Kwon, YH1
Nam, SY1
Bae, HI1
Seo, AN1
Han, X1
Jiang, K1
Wang, B1
Zhou, L1
Chen, X1
Li, S1

Trials

2 trials available for opc 12759 and Metaplasia

ArticleYear
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:6

    Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori;

2022
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
    Clinical drug investigation, 2015, Volume: 35, Issue:10

    Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicoba

2015